{"hands_on_practices": [{"introduction": "The foundation of mass spectrometry-based proteomics is the precise measurement of mass. Before a mass spectrometer can identify a peptide, we must first be able to predict the theoretical mass of any given peptide sequence. This exercise guides you through this fundamental calculation from first principles, starting with the elemental composition of individual amino acids. By methodically accounting for the atoms lost during peptide bond formation and gained from chemical modifications, you will compute a peptide's exact monoisotopic neutral mass and its corresponding mass-to-charge ratio ($m/z$) as it would appear in a spectrum. Mastering this core skill is essential for understanding how peptide identification algorithms work and for troubleshooting unexpected results in experimental data.", "problem": "You are analyzing the peptide with sequence given in the standard one-letter code as ACDEFGHIK. The cysteine residue is irreversibly alkylated by carbamidomethylation during iodoacetamide treatment. Assume the following foundational facts:\n- A peptide formed from $n$ free amino acids has $n-1$ peptide bonds, each formed by the loss of one molecule of water ($\\text{H}_2\\text{O}$).\n- The monoisotopic neutral mass of a molecule is the sum over elements of the product of each element’s monoisotopic atomic mass and its atom count in the molecule.\n- In positive-ion electrospray ionization, the $[\\text{M} + z\\text{H}]^{z+}$ ion’s mass-to-charge ratio is $(M + z m_{\\text{p}})/z$, where $M$ is the neutral monoisotopic mass and $m_{\\text{p}}$ is the monoisotopic mass of a proton.\n\nUse only the atomic-level composition and the monoisotopic atomic masses provided below. Work from the elemental formulas of the free (uncharged) amino acids and account explicitly for peptide bond formation and the modification.\n\nFree amino acid elemental formulas (each entry is $\\text{C}_x\\text{H}_y\\text{N}_z\\text{O}_w\\text{S}_v$):\n- $\\text{A}$ ($\\text{Ala}$): $\\text{C}_3\\text{H}_7\\text{N}_1\\text{O}_2$\n- $\\text{C}$ ($\\text{Cys}$): $\\text{C}_3\\text{H}_7\\text{N}_1\\text{O}_2\\text{S}_1$\n- $\\text{D}$ ($\\text{Asp}$): $\\text{C}_4\\text{H}_7\\text{N}_1\\text{O}_4$\n- $\\text{E}$ ($\\text{Glu}$): $\\text{C}_5\\text{H}_9\\text{N}_1\\text{O}_4$\n- $\\text{F}$ ($\\text{Phe}$): $\\text{C}_9\\text{H}_{11}\\text{N}_1\\text{O}_2$\n- $\\text{G}$ ($\\text{Gly}$): $\\text{C}_2\\text{H}_5\\text{N}_1\\text{O}_2$\n- $\\text{H}$ ($\\text{His}$): $\\text{C}_6\\text{H}_9\\text{N}_3\\text{O}_2$\n- $\\text{I}$ ($\\text{Ile}$): $\\text{C}_6\\text{H}_{13}\\text{N}_1\\text{O}_2$\n- $\\text{K}$ ($\\text{Lys}$): $\\text{C}_6\\text{H}_{14}\\text{N}_2\\text{O}_2$\n\nCarbamidomethyl modification on cysteine adds the group with elemental composition $\\text{C}_2\\text{H}_3\\text{N}_1\\text{O}_1$ to the peptide.\n\nMonoisotopic atomic masses to be used:\n- $m(^{12}\\text{C}) = 12.000000$\n- $m(^{1}\\text{H}) = 1.007825$\n- $m(^{14}\\text{N}) = 14.003074$\n- $m(^{16}\\text{O}) = 15.994915$\n- $m(^{32}\\text{S}) = 31.972071$\n- Proton mass $m_{\\text{p}} = 1.007276$\n\nTask:\n1. Derive the peptide’s overall elemental composition starting from the free amino acid formulas, subtracting $n-1$ molecules of $\\text{H}_2\\text{O}$ for $n = 9$, and adding the carbamidomethyl group on the single cysteine.\n2. Using the provided monoisotopic atomic masses, calculate the peptide’s monoisotopic neutral mass $M$ in daltons.\n3. Calculate the monoisotopic $[\\text{M} + 2\\text{H}]^{2+}$ mass-to-charge ratio $(M + 2 m_{\\text{p}})/2$.\n\nReport two numbers in this order:\n- First, the monoisotopic neutral mass in daltons.\n- Second, the monoisotopic $[\\text{M} + 2\\text{H}]^{2+}$ mass-to-charge ratio.\n\nRound both answers to six significant figures. Express the neutral mass in daltons and the mass-to-charge ratio as a pure number (dimensionless $m/z$).", "solution": "We begin from the fundamental definition that the monoisotopic neutral mass $M$ equals the sum over elements of the product of the monoisotopic atomic mass and the atom count in the molecule. The peptide sequence is ACDEFGHIK, which contains $n = 9$ amino acids and thus $n - 1 = 8$ peptide bonds, each formed by loss of one $\\text{H}_2\\text{O}$. The cysteine is modified by carbamidomethylation, adding $\\text{C}_2\\text{H}_3\\text{N}_1\\text{O}_1$.\n\nStep 1: Sum the elemental formulas of the free amino acids.\n\nUsing the provided formulas for the free amino acids:\n- A: $\\text{C}_3\\text{H}_7\\text{N}_1\\text{O}_2$\n- C: $\\text{C}_3\\text{H}_7\\text{N}_1\\text{O}_2\\text{S}_1$\n- D: $\\text{C}_4\\text{H}_7\\text{N}_1\\text{O}_4$\n- E: $\\text{C}_5\\text{H}_9\\text{N}_1\\text{O}_4$\n- F: $\\text{C}_9\\text{H}_{11}\\text{N}_1\\text{O}_2$\n- G: $\\text{C}_2\\text{H}_5\\text{N}_1\\text{O}_2$\n- H: $\\text{C}_6\\text{H}_9\\text{N}_3\\text{O}_2$\n- I: $\\text{C}_6\\text{H}_{13}\\text{N}_1\\text{O}_2$\n- K: $\\text{C}_6\\text{H}_{14}\\text{N}_2\\text{O}_2$\n\nSumming element-wise across the $9$ residues gives total counts:\n- Carbon: $3 + 3 + 4 + 5 + 9 + 2 + 6 + 6 + 6 = 44$\n- Hydrogen: $7 + 7 + 7 + 9 + 11 + 5 + 9 + 13 + 14 = 82$\n- Nitrogen: $1 + 1 + 1 + 1 + 1 + 1 + 3 + 1 + 2 = 12$\n- Oxygen: $2 + 2 + 4 + 4 + 2 + 2 + 2 + 2 + 2 = 22$\n- Sulfur: $0 + 1 + 0 + 0 + 0 + 0 + 0 + 0 + 0 = 1$\n\nTherefore, before condensation, the combined formula is $\\text{C}_{44}\\text{H}_{82}\\text{N}_{12}\\text{O}_{22}\\text{S}_{1}$.\n\nStep 2: Account for peptide bond formation by subtracting $8$ molecules of water.\n\nEach peptide bond is formed with loss of one $\\text{H}_2\\text{O}$; thus subtract $8 \\times \\text{H}_2\\text{O} = \\text{H}_{16}\\text{O}_{8}$:\n- Carbon: remains $44$\n- Hydrogen: $82 - 16 = 66$\n- Nitrogen: remains $12$\n- Oxygen: $22 - 8 = 14$\n- Sulfur: remains $1$\n\nThe peptide (unmodified) is thus $\\text{C}_{44}\\text{H}_{66}\\text{N}_{12}\\text{O}_{14}\\text{S}_{1}$.\n\nStep 3: Add the carbamidomethyl modification to cysteine.\n\nCarbamidomethyl adds $\\text{C}_2\\text{H}_3\\text{N}_1\\text{O}_1$. Adding this to the peptide gives:\n- Carbon: $44 + 2 = 46$\n- Hydrogen: $66 + 3 = 69$\n- Nitrogen: $12 + 1 = 13$\n- Oxygen: $14 + 1 = 15$\n- Sulfur: $1$\n\nTherefore, the final elemental composition is $\\text{C}_{46}\\text{H}_{69}\\text{N}_{13}\\text{O}_{15}\\text{S}_{1}$.\n\nStep 4: Compute the monoisotopic neutral mass $M$.\n\nUsing the provided monoisotopic atomic masses,\n$m(^{12}\\text{C}) = 12.000000$, $m(^{1}\\text{H}) = 1.007825$, $m(^{14}\\text{N}) = 14.003074$, $m(^{16}\\text{O}) = 15.994915$, $m(^{32}\\text{S}) = 31.972071$, we calculate\n\n$$\nM\n= 46 \\times 12.000000\n+ 69 \\times 1.007825\n+ 13 \\times 14.003074\n+ 15 \\times 15.994915\n+ 1 \\times 31.972071.\n$$\n\nEvaluating term by term,\n\n$$\n46 \\times 12.000000 = 552.000000,\n$$\n\n\n$$\n69 \\times 1.007825 = 69.539925,\n$$\n\n\n$$\n13 \\times 14.003074 = 182.039962,\n$$\n\n\n$$\n15 \\times 15.994915 = 239.923725,\n$$\n\n\n$$\n1 \\times 31.972071 = 31.972071.\n$$\n\nSumming,\n\n$$\nM = 552.000000 + 69.539925 + 182.039962 + 239.923725 + 31.972071 = 1075.475683.\n$$\n\n\nStep 5: Compute the monoisotopic $[\\text{M} + 2\\text{H}]^{2+}$ mass-to-charge ratio.\n\nWith proton mass $m_{\\text{p}} = 1.007276$ and charge $z = 2$, the mass-to-charge ratio is\n\n$$\n\\frac{M + 2 m_{\\text{p}}}{2}\n= \\frac{1075.475683 + 2 \\times 1.007276}{2}\n= \\frac{1075.475683 + 2.014552}{2}\n= \\frac{1077.490235}{2}\n= 538.7451175.\n$$\n\n\nRounding to six significant figures as required:\n- Neutral monoisotopic mass $M$: $1075.48$.\n- $[\\text{M} + 2\\text{H}]^{2+}$ mass-to-charge: $538.745$.\n\nThe results are reported in the requested order.", "answer": "$$\\boxed{\\begin{pmatrix}1075.48 & 538.745\\end{pmatrix}}$$", "id": "2593843"}, {"introduction": "In electrospray ionization mass spectrometry (ESI-MS), analytes like peptides often acquire multiple charges (protons), resulting in a series of peaks in the spectrum for a single molecular species. While this may seem like a complication, it is a powerful feature that allows for the accurate determination of a peptide's neutral mass, even if its identity is unknown. This hands-on practice challenges you to work backward from two experimentally observed mass-to-charge ($m/z$) values to deduce the parent peptide's neutral mass, $M$. You will also learn to assess the internal consistency of your measurements by calculating the mass error in parts-per-million (ppm), a critical metric for a confident identification.", "problem": "An Electrospray Ionization Mass Spectrometry (ESI-MS) experiment detects a peptide in two charge states. In ESI-MS, a peptide carrying $z$ charges from protons has an ion mass equal to the neutral monoisotopic mass plus the mass of the $z$ added protons, and the instrument reports the mass-to-charge ratio as the total ion mass divided by $z$. Assume all charges arise solely from protonation, and neglect adducts or neutral losses. Use the following data:\n- Observed charge states: $z=2$ and $z=3$.\n- Reported $m/z$ values: for $z=2$, $m/z = 895.973776467$; for $z=3$, $m/z = 597.650276467$.\n- Monoisotopic mass of a proton: $m_{\\mathrm{p}} = 1.00727646688\\ \\mathrm{Da}$.\n\nTasks:\n1. From first principles, write the relation connecting the neutral monoisotopic mass $M$ of the peptide, the observed charge $z$, the proton mass $m_{\\mathrm{p}}$, and the measured mass-to-charge ratio $m/z$. Use it to compute two independent estimates of $M$, one from each observed charge state.\n2. Compute the mean neutral mass $\\bar{M}$ of these two estimates, the absolute mass difference $\\Delta = |M_{(z=2)} - M_{(z=3)}|$, and the parts-per-million discrepancy $\\delta_{\\mathrm{ppm}} = \\left(\\Delta / \\bar{M}\\right)\\times 10^{6}$.\n3. Decide whether the two measurements are mutually consistent within $5$ parts per million relative to $\\bar{M}$.\n\nProvide as your final numeric answer the value of $\\delta_{\\mathrm{ppm}}$, rounded to four significant figures. Report the value as a pure number in parts per million (do not append a unit symbol).", "solution": "The fundamental relationship in Electrospray Ionization Mass Spectrometry (ESI-MS) for a peptide of neutral monoisotopic mass $M$ that has been ionized by the addition of $z$ protons is based on the definition of the mass-to-charge ratio, denoted as $(m/z)$. The mass of the resulting ion, $M_{ion}$, is the sum of the neutral mass of the peptide and the mass of the $z$ added protons, where $m_{\\mathrm{p}}$ is the mass of a single proton.\n$$M_{ion} = M + z \\cdot m_{\\mathrm{p}}$$\nThe mass spectrometer measures the ratio of this ion mass to its charge number $z$. Let us denote the measured value as $R_{obs} = (m/z)_{obs}$.\n$$R_{obs} = \\frac{M_{ion}}{z} = \\frac{M + z \\cdot m_{\\mathrm{p}}}{z}$$\nTo compute the neutral mass $M$ from an observed measurement, we must rearrange this expression algebraically:\n$$z \\cdot R_{obs} = M + z \\cdot m_{\\mathrm{p}}$$\n$$M = z \\cdot R_{obs} - z \\cdot m_{\\mathrm{p}}$$\nFactoring out $z$, we obtain the equation for calculating the neutral mass from the experimental data:\n$$M = z \\cdot (R_{obs} - m_{\\mathrm{p}})$$\n\nThe problem provides data for two charge states, $z=2$ and $z=3$. We will use the provided values to compute two independent estimates of $M$.\nGiven data:\nFor the charge state $z_1 = 2$, the reported $m/z$ is $R_1 = 895.973776467$.\nFor the charge state $z_2 = 3$, the reported $m/z$ is $R_2 = 597.650276467$.\nThe monoisotopic mass of a proton is $m_{\\mathrm{p}} = 1.00727646688$.\n\nUsing the derived formula for $M$, we calculate the first estimate, $M_{(z=2)}$, from the data for the $z=2$ charge state:\n$$M_{(z=2)} = z_1 \\cdot (R_1 - m_{\\mathrm{p}})$$\n$$M_{(z=2)} = 2 \\cdot (895.973776467 - 1.00727646688)$$\n$$M_{(z=2)} = 2 \\cdot (894.96650000012) = 1789.93300000024$$\n\nNext, we calculate the second estimate, $M_{(z=3)}$, from the data for the $z=3$ charge state:\n$$M_{(z=3)} = z_2 \\cdot (R_2 - m_{\\mathrm{p}})$$\n$$M_{(z=3)} = 3 \\cdot (597.650276467 - 1.00727646688)$$\n$$M_{(z=3)} = 3 \\cdot (596.64300000012) = 1789.92900000036$$\n\nThe second task requires the computation of the mean neutral mass $\\bar{M}$, the absolute mass difference $\\Delta$, and the parts-per-million discrepancy $\\delta_{\\mathrm{ppm}}$.\n\nThe mean neutral mass $\\bar{M}$ is the arithmetic average of the two estimates:\n$$\\bar{M} = \\frac{M_{(z=2)} + M_{(z=3)}}{2}$$\n$$\\bar{M} = \\frac{1789.93300000024 + 1789.92900000036}{2} = \\frac{3579.8620000006}{2} = 1789.9310000003$$\n\nThe absolute mass difference $\\Delta$ is:\n$$\\Delta = |M_{(z=2)} - M_{(z=3)}|$$\n$$\\Delta = |1789.93300000024 - 1789.92900000036| = 0.00399999988$$\n\nThe parts-per-million discrepancy $\\delta_{\\mathrm{ppm}}$ is defined as the ratio of the absolute mass difference to the mean mass, multiplied by $10^6$:\n$$\\delta_{\\mathrm{ppm}} = \\left(\\frac{\\Delta}{\\bar{M}}\\right) \\times 10^6$$\n$$\\delta_{\\mathrm{ppm}} = \\left(\\frac{0.00399999988}{1789.9310000003}\\right) \\times 10^6 \\approx 2.2347306$$\n\nSince $2.235  5$, the two measurements are mutually consistent within the specified tolerance.\n\nThe final numeric answer required is the value of $\\delta_{\\mathrm{ppm}}$ rounded to four significant figures.\nRounding $2.2347306$ to four significant figures yields $2.235$.", "answer": "$$\\boxed{2.235}$$", "id": "2593781"}, {"introduction": "Identifying a peptide's mass is only the first step; to understand its function, we often need to know its precise structure, including the location of any post-translational modifications (PTMs). This is achieved through tandem mass spectrometry (MS/MS), where peptide ions are fragmented to reveal sequence-specific information. This problem simulates a common and critical challenge in phosphoproteomics: localizing a single phosphate group between two potential amino acid sites. By analyzing a given set of fragment ions ($b$- and $y$-ions), you will learn to identify the key \"site-determining ions\" that provide conclusive evidence for the modification's exact position.", "problem": "A singly phosphorylated peptide with sequence G S A T L N V K (N- to C-terminus) is analyzed by higher-energy collisional dissociation (HCD) tandem mass spectrometry. The two plausible phosphorylation sites are the serine at position $2$ and the threonine at position $4$, which are separated by one residue (alanine at position $3$). The observed HCD spectrum shows confident sequence ions as follows (indices refer to standard $b_i$ and $y_j$ nomenclature): $b_1$, $b_2$, $b_4$, $b_5$, $y_2$, $y_4$, $y_5$, and $y_7$. Among these, the following phosphate-retaining fragment species are specifically observed: $y_5$ carrying an added mass of approximately $+79.9663$ relative to its unmodified composition, and $b_4$ and $y_7$ also carrying approximately $+79.9663$. The $b_2$ ion is observed only at its unmodified mass (no corresponding $+79.9663$ species is detected). The $b_3$ and $y_6$ ions are not detected at either their unmodified or phosphate-retaining masses. Assume a single phosphorylation on either the serine ($2$) or the threonine ($4$) and that fragments carry the phosphate only if the modified residue is contained in the fragment.\n\nWhich of the following best specifies the site-determining ions required to localize the phosphate between positions $2$ and $4$, and, given the observed spectrum, whether it is in principle sufficient for unambiguous site localization under HCD?\n\nA. Site-determining ions are $b_2$ and $b_3$ (which include serine but exclude threonine) and $y_5$ and $y_6$ (which include threonine but exclude serine); the spectrum is sufficient because a phosphate-retaining $y_5$ is observed even though $b_3$ and $y_6$ are absent.\n\nB. Site-determining ions are $b_4$ and $y_7$ (because they include most residues and are typically intense); the spectrum is sufficient because both $b_4$ and $y_7$ retain phosphate.\n\nC. Site-determining ions are $a$-type fragments from the N-terminus across the serine and $y_2$ from the C-terminus; the spectrum is insufficient because no $a$-type ions are reported.\n\nD. Site-determining ions are electron-transfer dissociation $c$- and $z^\\bullet$-type fragments that bracket positions $2$ and $4$; the HCD spectrum cannot in principle localize serine/threonine phosphorylation and is therefore insufficient regardless of the observed $b/y$ ions.", "solution": "The core principle of localizing a post-translational modification (PTM) using tandem mass spectrometry is to identify \"site-determining ions\". These are fragment ions that contain one of the potential modification sites but exclude the other(s). By observing whether such an ion carries the mass of the PTM, its location can be deduced.\n\nThe peptide sequence is G(1)-S(2)-A(3)-T(4)-L(5)-N(6)-V(7)-K(8). The two potential phosphorylation sites are Serine at position $2$ (S2) and Threonine at position $4$ (T4).\n\nLet us define the sequences of the relevant N-terminal $b$-ions and C-terminal $y$-ions:\n- **b-ions (from N-terminus):**\n  - $b_1$: G\n  - $b_2$: GS (contains S2, not T4)\n  - $b_3$: GSA (contains S2, not T4)\n  - $b_4$: GSAT (contains both S2 and T4)\n- **y-ions (from C-terminus):**\n  - $y_1$: K\n  - $y_2$: VK\n  - $y_3$: NVK\n  - $y_4$: LNV K\n  - $y_5$: TLNV K (contains T4, not S2)\n  - $y_6$: ATLNV K (contains T4, not S2)\n  - $y_7$: SATLNV K (contains both S2 and T4)\n\nFrom this, the site-determining ions are:\n- To localize the phosphate to S2: $b_2$ and $b_3$. If the phosphate is on S2, these ions should be observed with an added mass of $+79.9663$ Da.\n- To localize the phosphate to T4: $y_5$ and $y_6$. If the phosphate is on T4, these ions should be observed with an added mass of $+79.9663$ Da.\n\nIons that contain both potential sites, such as $b_4$ and $y_7$, are *not* site-determining. Observing them in their phosphorylated form only confirms that the modification is present somewhere within their sequence, but not specifically on S2 or T4.\n\nNow, let us analyze the experimental observations:\n1.  **Observation of unmodified $b_2$:** The problem states that the $b_2$ ion (sequence GS) is observed *only* at its unmodified mass. Since this ion contains S2 but not T4, this is strong evidence that S2 is *not* phosphorylated.\n2.  **Observation of phosphorylated $y_5$:** The problem states that the $y_5$ ion (sequence TLNVK) is observed with the added mass of a phosphate group. Since this ion contains T4 but not S2, this is strong evidence that T4 *is* phosphorylated.\n3.  **Observation of phosphorylated $b_4$ and $y_7$:** These ions (GSAT and SATLNV K, respectively) contain both sites. Their observation in a phosphorylated state is consistent with phosphorylation at T4, but they do not provide localizing information on their own.\n4.  **Absence of $b_3$ and $y_6$:** The absence of a fragment ion in a mass spectrum is not conclusive evidence of anything. Fragments may not form or be detected due to chemical instability or low abundance. No conclusion can be drawn from their absence.\n\nBased on the observation of an unmodified $b_2$ ion and a phosphorylated $y_5$ ion, the spectral data are sufficient to unambiguously localize the single phosphate group to the threonine residue at position $4$.\n\n**Evaluation of Options**\n\n**A. Site-determining ions are $b_2$ and $b_3$ (which include serine but exclude threonine) and $y_5$ and $y_6$ (which include threonine but exclude serine); the spectrum is sufficient because a phosphate-retaining $y_5$ is observed even though $b_3$ and $y_6$ are absent.**\nThis statement is correct. First, it correctly identifies the set of ions that are truly site-determining for distinguishing between phosphorylation at S2 and T4. These are precisely the ions that contain one site but not the other. Second, it correctly concludes that the observation of one such key ion ($y_5(+P)$) is sufficient for localization. The mention that the absence of $b_3$ and $y_6$ does not preclude localization is also a correct and important point in mass spectrometry data interpretation. While the statement does not mention the complementary evidence from the unmodified $b_2$ ion, the logic it presents is sound and leads to the correct conclusion based on the provided data.\n**Verdict: Correct**\n\n**B. Site-determining ions are $b_4$ and $y_7$ (because they include most residues and are typically intense); the spectrum is sufficient because both $b_4$ and $y_7$ retain phosphate.**\nThis statement is fundamentally flawed. As established, $b_4$ and $y_7$ contain both S2 and T4. Therefore, they are by definition *not* site-determining ions. They cannot be used to distinguish between phosphorylation at S2 versus T4. Observing them in a phosphorylated state only confirms the presence of the modification somewhere within their respective sequences.\n**Verdict: Incorrect**\n\n**C. Site-determining ions are $a$-type fragments from the N-terminus across the serine and $y_2$ from the C-terminus; the spectrum is insufficient because no $a$-type ions are reported.**\nThis statement is incorrect. While $a$-type ions can exist, they are not uniquely required for localization when $b$-ions are present. More importantly, the $y_2$ ion (sequence VK) contains neither of the potential phosphorylation sites (S2, T4) and is therefore not a site-determining ion in this context. The premise of which ions are determining is incorrect, and thus the conclusion of insufficiency is unfounded.\n**Verdict: Incorrect**\n\n**D. Site-determining ions are electron-transfer dissociation $c$- and $z^\\bullet$-type fragments that bracket positions $2$ and $4$; the HCD spectrum cannot in principle localize serine/threonine phosphorylation and is therefore insufficient regardless of the observed $b/y$ ions.**\nThis statement is incorrect on multiple grounds. First, it introduces an irrelevant fragmentation method, electron-transfer dissociation (ETD), which produces $c$- and $z$-ions. The problem explicitly states that HCD was used, which produces $b$- and $y$-ions. Second, it makes the false claim that HCD \"cannot in principle localize serine/threonine phosphorylation\". While HCD can induce neutral loss of the phosphate group, making localization difficult in some cases, it is not impossible in principle. In fact, the problem explicitly states that phosphate-retaining fragments were observed, demonstrating that localization is possible in this very case.\n**Verdict: Incorrect**", "answer": "$$\\boxed{A}$$", "id": "2593787"}]}